Cancer patients more likely to use marijuana-How it Helps Cancer Patient

0
71
Cancer patients more likely to use marijuana

Cancer patients more likely to use marijuana:-Cancer Americans are more likely to use marijuana and prescription opioid without cancer, and this group is increasing the use of medical marijuana, new research shows. Pain in cancer patients is common, but many do not get enough pain relief, researchers said.
In the new study, more than 800 adults were seen with cancer, who participated in the National Health and Nutrition Examination, U.S., Survey between 2005 and 2014. The patients were compared with 1,650 adults without cancer.

Cancer patients more likely to use marijuana: Study

The findings have shown that 40% of cancer patients had used marijuana within the last year, while 38% of patients without cancer. Even people with cancer were more likely to use unprotected prescription opioids – more than 14% versus 6%, respectively.
While analyzing the rates of the use of marijuana and opioids between more than 19,000 survey respondents and non-cancerous marijuana and opioids, investigators found increasing rates of marijuana use during the 10-year study period, perhaps because of legislative changes in its availability Increased.

Dr. Kathryn Ries Tringale, the co-author of the University of California’s San Diego, says that the need for more clinical trials is to show how effective medical marijuana is against cancer-related pain. Catherine Rins Tringle said.

Study writers said that prescription opioid was used in cancer patients. According to a study published online in Journal Cancer on 22 April, between 2005 and 2014, cancer diagnosis did not affect the possibility of misuse of the substance.

The study co-authored by Dr. Jona Hattangadi-Gluth mentions that the legalization of medical marijuana is associated with the decline in hospital for opioid misuse or dependence. If patients are replacing marijuana for opioid, then it can be an opportunity to reduce opiate-related illness and death, he suggested.

Jona Hattangadi-Gluth said in a newsletter news release, “Of course, it will also be important to identify the risks and adverse effects of marijuana, which have not been studied at large random diagnostic tests before, considering its timeliness as a class 1 controlled substance.”

For Latest News:- www.indiatimelines.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here